Factors influencing postembolization syndrome in patients with hepatocellular carcinoma undergoing first transcatheter arterial chemoembolization

被引:17
|
作者
He, Jing-Jing [1 ]
Yin, Xi-Xi [1 ]
Wang, Ting [1 ]
Chen, Min-Ying [1 ]
Li, Xi-Long [1 ]
Yang, Xin-Jing [1 ]
Shao, Hong-Yan [1 ]
机构
[1] Sun Yat Sen Univ, Canc Ctr, Guangzhou, Guangdong, Peoples R China
关键词
Hepatocellular carcinoma; postembolization syndrome; transcatheter arterial chemoembolization; HEPATIC TRANSARTERIAL CHEMOEMBOLIZATION; POST-EMBOLIZATION SYNDROME; RISK-FACTORS; MANAGEMENT; EFFICACY; CANCER; SAFETY; BEADS;
D O I
10.4103/jcrt.jcrt_132_21
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Context: Postembolization syndrome (PES) is the most common complication in patients with hepatocellular carcinoma (HCC) who had undergone transcatheter arterial chemoembolization (TACE). PES was defined as fever, nausea and/or vomiting, and abdominal pain and these symptoms develop within 1-3 days after TACE. However, few studies have explored the factors influencing PES in patients with TACE for the first time. Aims: We explored the factors influencing PES in patients with HCC undergoing TACE for the first time. Settings and Design: The present study was a hospital-based study conducted in the tertiary care hospital of Guangzhou with a retrospective study design. Subjects and Methods: In this single-center retrospective study, a total of 242 patients with HCC were included in the first TACE program between November 1, 2018 and November 31, 2019. Statistical Analysis Used: T-test and Chi-square test revealed the factors affecting the occurrence of PES. Correlation analysis (Spearman) explored the relationship between these factors and PES. Binary logistics analyzed the predictive factors of PES. Results: The probability of PES in patients with HCC undergoing TACE for the first time was 55.45%. Types of embolic agents (r = 0.296), types of microspheres (r = 0.510), number of microspheres (r = 0.130), maximum diameter of microspheres used (r = 0.429), type of drug (r = 0.406), and drug loading (r = 0.433) were positively correlated with PES (P < 0.05). Serum albumin was negatively correlated with PES (P = 0.008, r = -0.170). Binary logistic regression analysis revealed that drug loading microspheres (odds ratio [OR] = 0.075, 95% confidence interval [CI] = 0.031-0.180) and serum albumin (OR = 0.182, 95% CI = 0.068-0.487) were the protective factors influencing PES, while drug loading was the risk factor of PES (OR = 1.407, 95% CI = 1.144-1.173). Conclusions: Drug loading microspheres, serum albumin, and drug loading were the predictors of PES after the first TACE.
引用
收藏
页码:777 / 783
页数:7
相关论文
共 50 条
  • [1] Development of a predictive nomogram for postembolization syndrome after transcatheter arterial chemoembolization of hepatocellular carcinoma
    Jinfeng Bai
    Ming Huang
    Jinmei Zhou
    Bohan Song
    Jianjie Hua
    Rong Ding
    Scientific Reports, 14
  • [2] Development of a predictive nomogram for postembolization syndrome after transcatheter arterial chemoembolization of hepatocellular carcinoma
    Bai, Jinfeng
    Huang, Ming
    Zhou, Jinmei
    Song, Bohan
    Hua, Jianjie
    Ding, Rong
    SCIENTIFIC REPORTS, 2024, 14 (01)
  • [3] A new horizon in the prevention of the postembolization syndrome after transcatheter arterial chemoembolization for hepatocellular carcinoma
    Piscaglia, Fabio
    Tovoli, Francesco
    Pini, Patrizia
    Salvatore, Veronica
    HEPATOLOGY, 2018, 67 (02) : 467 - 469
  • [4] Risk Factors for Postembolization Syndrome after Transcatheter Arterial Chemoembolization
    Arslan, Muhammet
    Degirmencioglu, Serkan
    CURRENT MEDICAL IMAGING REVIEWS, 2019, 15 (04) : 380 - 385
  • [5] Cytokines are associated with postembolization fever and survival in hepatocellular carcinoma patients receiving transcatheter arterial chemoembolization
    Chao, Yee
    Wu, Chen-Yi
    Kuo, Chen-Yu
    Wang, Jack P.
    Luo, Jiing-Chyuan
    Kao, Chien-Hui
    Lee, Rheun-Chuan
    Lee, Wei-Ping
    Li, Chung-Pin
    HEPATOLOGY INTERNATIONAL, 2013, 7 (03) : 883 - 892
  • [6] The Efficacy and Safety of Steroids for Preventing Postembolization Syndrome after Transcatheter Arterial Chemoembolization of Hepatocellular Carcinoma
    Kuwaki, Kenji
    Nouso, Kazuhiro
    Miyashita, Manabi
    Makino, Yasuhiro
    Hagihara, Hiroaki
    Moriya, Akio
    Adachi, Takuya
    Wada, Nozomu
    Yasunaka, Yuki
    Yasunaka, Tetsuya
    Takeuchi, Yasuto
    Onishi, Hideki
    Nakamur, Shinichiro
    Iked, Fusao
    Shiraha, Hidenori
    Takaki, Akinobu
    Okada, Hiroyuki
    ACTA MEDICA OKAYAMA, 2019, 73 (04) : 333 - 339
  • [7] Cytokines are associated with postembolization fever and survival in hepatocellular carcinoma patients receiving transcatheter arterial chemoembolization
    Yee Chao
    Chen-Yi Wu
    Chen-Yu Kuo
    Jack P. Wang
    Jiing-Chyuan Luo
    Chien-Hui Kao
    Rheun-Chuan Lee
    Wei-Ping Lee
    Chung-Pin Li
    Hepatology International, 2013, 7 : 883 - 892
  • [8] Influencing factors related to transcatheter arterial chemoembolization for hepatocellular carcinoma patients achieved tumor response
    Shao, Hongyan
    Deng, Juan
    Xie, Luping
    Zheng, Qiwen
    Zou, Bihui
    Deng, Jun
    Zhang, Tianqi
    He, Jingjing
    JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 2022, 18 (02) : 560 - 566
  • [9] Predictive factors of transcatheter arterial chemoembolization for hepatocellular carcinoma
    Ishii, H.
    Furuse, J.
    Nakachi, K.
    Suzuki, E.
    Shimizu, S.
    Yoshino, M.
    Satake, M.
    Hayashi, T.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [10] Transcatheter arterial chemoembolization of hepatocellular carcinoma
    Chung, JW
    HEPATO-GASTROENTEROLOGY, 1998, 45 : 1236 - 1241